| 发明名称 |
A PHARMACEUTICAL FORMULATION COMPRISING A PYRIMIDINE-4-ONE DERIVATIVE COATED WITH AN ENTERIC POLYMER |
| 摘要 |
THE PRESENT INVENTION PROVIDES ENTERIC POLYMER COATED TABLET FORMULATIONS FOR ORAL ADMINISTRATION WHICH COMPRISE A PHOSPHOLIPASE A2 ENZYME LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITOR, PROCESSES FOR PREPARING SUCH FORMULATIONS AND THEIR USE IN THERAPY, IN PARTICULAR THE TREATMENT OF ATHEROSCLEROSIS.
|
| 申请公布号 |
MY139165(A) |
申请公布日期 |
2009.08.28 |
| 申请号 |
MYPI20043561 |
申请日期 |
2004.09.01 |
| 申请人 |
GLAXO GROUP LIMITED |
发明人 |
DIRK MARINUS JOHANNES VAN SCHIE |
| 分类号 |
A61K31/513;A61K9/20;A61K9/28;A61K9/30;A61K9/56;A61P9/10 |
主分类号 |
A61K31/513 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
